Finnish biotechnology company Biohit Oyj (HEL:BIOBV) on Friday introduced the Biohit FAEX Sample System, a new stool sample collection and handling solution designed for seamless integration into diagnostic workflows.
According to Biohit, the system enhances precision, efficiency and flexibility for both patients and laboratories.
The Biohit FAEX Sample System functions as both a standard test tube and a dropper tube, ensuring accurate and reproducible sample dispensing for ELISAs, chemiluminescence assays, lateral flow tests and proprietary diagnostic kits. A precision-engineered collection stick enables consistent sample collection, while a screw-tight cap with leak-proof threads ensures safe handling, transport and storage.
CE-marked and compliant with Regulation (EU) 2017/746 for In Vitro Diagnostic Devices, the system meets high regulatory standards. It can be used as a standalone component or as part of a diagnostic kit, offering a practical and reliable solution for stool sample processing.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system